ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Bond Rout and M&A Drive Options Signals

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

The biggest macro signal right now is in the bond market. US 10-year Treasury yields hit their highest level since 2002 this week. That move is pushing options traders toward rate-sensitive plays across equities.

The clearest M&A options spike comes from ON and SYNA. Onsemi agreed to acquire Synaptics for $123 per share in cash. Synaptics has a short score of 46 and sits up 37% year-to-date. Options activity in both names jumped on the announcement. ON carries a short score of 43 and is up 42% this year.

NKE stands out as a potential vol play. The stock is down 44% year-to-date. Its RSI sits at just 35, deep in oversold territory. Days to cover have stretched to 4.7. The short score is 51. With earnings approaching, options traders face a compressed, beaten-up name carrying real squeeze potential.

Chip stocks attract the heaviest negative-bet volume on the ORTEX screen this week. MU leads that list. Its stock score is 93.9 out of 100. Analysts see 43% upside. Taiwan's August export orders hit a record $103 billion, up 71% from last year's best, per ORTEX Alt Data. That macro backdrop supports chip demand but also invites profit-taking hedges through puts.

NFLX drew fresh options attention after reports it plans to open its content to movie theaters. Its options score is elevated on the ORTEX 7-day screen. KKR's warning about AI credit concentration added a cautious overlay to broader tech options flow.

Stocks in this article

How this article was generated

Generated
1 Oct 2026, 20:42
Prompt version
v1.0
Data sources
Options flowORTEX Alpha signalsAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.